Explaining Mankind Pharma's IPO
Finshots Daily
00:00
The Future of Mankind
In the past year or so, mankind is charting a new path. It's shifting from drugs for acute illnesses to chronic therapies such as diabetes and heart disease. This segment not only gives them more pricing power, but the revenues are also more predictable. But it's still not an easy shift to make. And does mankind have the ability to make that shift?
Play episode from 04:08
Transcript
